Phreesia Posts 13% Revenue Growth, Holds Full-Year Guidance

Healthcare intake software company Phreesia (NYSE: PHR) posted first-quarter fiscal 2027 revenue of $130.9 million, Benzinga reported Wednesday. That figure represents a 13% increase compared with the same period one year prior.

Payments and Network Drive the Quarter

Payment solutions emerged as the standout performer, with revenue climbing 40% year-over-year. Network solutions added a further 15% gain, pointing to a meaningful shift in where Phreesia’s growth engine is running. To sharpen transparency around these lines, management introduced two new reporting metrics during the call. Total Managed Payments and Payment Solutions Revenue Rate will now give investors a cleaner window into the company’s expanding payment ecosystem.

Chief Financial Officer Balaji Gandhi fielded much of the analyst questioning, alongside Chief Executive Officer Haim Indig. Analysts from Wells Fargo, KeyBank, and Jefferies all pressed management on how the company’s go-to-market strategy is evolving. With subscription revenue becoming a smaller part of the story, sales and marketing teams are reportedly being repositioned to chase growth in payments and network channels.

Also Read: What Is a Fiscal Year and Why Do Companies Use Them?

Background: Phreesia’s Shift Toward Payments

Phreesia originally built its business around patient intake software for healthcare providers. Over recent years, the company has moved deliberately toward monetising the payment flows that run through its platform. The acquisition of AccessOne, a patient financing business, accelerated that pivot. Management highlighted efforts to weave AccessOne’s financing tools deeper into Phreesia’s broader product suite. The company also expanded AccessOne’s securitization facility with PNC Bank during the quarter, a move that provides additional capacity to fund patient payment plans.

On the capital structure side, Phreesia refinanced an existing bridge loan with a new $275 million credit facility. That refinancing reduces near-term financing risk and extends the company’s financial runway as it invests in growth.

Also Read: Healthcare Technology Sector Overview

Guidance Held Despite Network Uncertainty

Despite flagging some variability in commitment levels among Network Solutions clients, Phreesia held its full-year fiscal 2027 revenue guidance range of $510 million to $520 million. Management pointed to artificial intelligence adoption as a lever for keeping operating costs in check even as headcount and infrastructure scale up. Analysts also pressed management on whether labor efficiency gains visible in sales and marketing figures during Q1 signal further margin expansion ahead.

Phreesia shares trade on the New York Stock Exchange under the ticker PHR.

Read Next: AI in Healthcare: What the Tech Wave Means for Hospital Software Stocks